East Nassau, NY, United States of America

Garry M Pilling

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: Albany Molecular Research, Inc., Amr Technology, Inc., Astra Aktiebolag. Active years: 2000-2013.

USPTO Granted Patents = 13 

% Patents Active = 61.5

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2000-2013

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Garry M Pilling: A Pioneer in East Nassau, NY

Introduction: Garry M Pilling, a distinguished inventor based in East Nassau, NY, stands out with an impressive portfolio of 13 patents. His groundbreaking work has significantly contributed to the field of chemistry and pharmaceuticals.

Latest Patents: Among his latest patents is the innovative process for the production of piperidine derivatives. This method involves a series of sequential steps resulting in the creation of compounds essential in the development of pharmaceutical products.

Career Highlights: Garry M Pilling has made substantial contributions to renowned companies like Albany Molecular Research, Inc., and AMR Technology, Inc. His expertise and commitment to innovation have played a pivotal role in advancing scientific research and discovery.

Collaborations: Throughout his career, Garry M Pilling has collaborated with industry experts such as Thomas E D'Ambra and Nils-ANGke Bergman. These partnerships have led to the successful implementation of novel ideas and the attainment of groundbreaking results in the field of pharmaceuticals.

Conclusion: In conclusion, Garry M Pilling's dedication to innovation and his exceptional problem-solving skills have solidified his position as a visionary inventor in East Nassau, NY. His relentless pursuit of excellence continues to inspire future generations of inventors and researchers in the quest for scientific advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…